Larimar Therapeutics (LRMR) Earnings Date & Reports

A.I. Advisor
published Earnings

LRMR is expected to report earnings to rise 13.07% to -30 cents per share on August 08

Larimar Therapeutics LRMR Stock Earnings Reports
Q2'24
Est.
$-0.31
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.05
Q3'23
Beat
by $0.01
Q2'23
Beat
by $0.01
The last earnings report on May 09 showed earnings per share of -27 cents, missing the estimate of -23 cents. With 316.31K shares outstanding, the current market capitalization sits at 594.63M.
View a ticker or compare two or three
LRMR
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com